Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Repertoire Immune Medicines

Request full access

Developing a new category of immune therapies for cancer, autoimmunity and infectious disease

Cambridge, United StatesFounded 2020Biotech & Life Sciences

About Repertoire Immune Medicines

Repertoire Immune Medicines is a biotechnology company operating in the healthcare and immunology sectors, focused on understanding and leveraging the human immune system to develop precise, immune-targeted therapies. The company was formed in 2020 through the merger of two Flagship Pioneering–founded ventures, Cogen Immune Medicines and Torque Therapeutics, combining complementary technologies in immune decoding and cellular immunotherapy.

Repertoire’s work centers on cellular immunity, particularly the interactions between antigens and T-cell receptors (TCRs). By studying immune synapses at scale, the company aims to identify and engineer therapeutic immune responses that can be applied across diseases such as cancer, autoimmune disorders, and infectious diseases. Its approach integrates experimental biology with computational analysis to map immune recognition and translate those insights into drug candidates.

Operating within the biotechnology market, Repertoire’s business model is based on the research, development, and eventual commercialization of novel immune medicines. These therapies are designed to harness or redirect the body’s own T cells to achieve more targeted and effective disease treatment. In addition to product development, the company may pursue collaborations, licensing arrangements, or partnerships with pharmaceutical companies to advance its programs.

Revenue generation is expected to come primarily from the development and sale of proprietary immune-based therapeutics, with potential supplemental income from strategic partnerships and research collaborations typical of the biotech industry.

Source: Dealroom company data

At a glance

Status
Operational
Employees
85
Open positions
5
Dealroom signal
72.6/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Rumoured $1B, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Investment activity
3 companies, latest Oct 2020
Capital deployed
—
Preferred round
MERGER

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Apr 2021 $189M $756M Invus · Flagship Pioneering · PSP Investments · SoftBank —
EARLY VCOther financing Mar 2020 $0 — JDRF T1D Fund ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Repertoire Immune Medicines website traffic

Latest recorded traffic for Repertoire Immune Medicines is 7.6K monthly website visits, up 55.1% over the last three months. Repertoire Immune Medicines's team declined 5.6% over the past year.

Latest monthly visits7.6K 3-month web change+55.1% 1-year team growth-5.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Repertoire Immune Medicines in the Cambridge ecosystem

Live from Dealroom

The Repertoire Immune Medicines office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

Team profiled 20 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States87.8%
🇨🇭 Switzerland10.8%
🇨🇳 China1.4%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Repertoire Immune Medicines on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Repertoire Immune Medicines’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.